- Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity-MIAMI BEACH, Fla., Nov. 7
- Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants-QUINCY, Mass., Nov. 6
- Osteotech Reports Third Quarter 2009 Financial Results-EATONTOWN, N.J., Nov. 5
- Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret-WELLINGTON, Colo., Nov. 5
- Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts-AURORA, Ontario, Nov. 5
- GenVec Reports Third Quarter 2009 Financial Results-GAITHERSBURG, Md., Nov. 5
- PDI Reports 2009 Third Quarter Financial Results-SADDLE RIVER, N.J., Nov. 5
- Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air-SAN DIEGO, Nov. 5
- Philanthropists, Medical Research Foundations, and Industry Leaders Gather in New York for Inaugural Partnering for Cures Meeting-WASHINGTON, Nov. 5
- RESEND: SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS-SAN DIEGO, CA, November 5, 2009
- GenVec Signs New Contract to Support HIV and Influenza Vaccine Development-GAITHERSBURG, Md., Nov. 5
- Symmetry Medical Reports Third Quarter 2009 Financial Results-WARSAW, Ind., Nov. 5
- NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations-NEW YORK, Nov. 4
- InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF-BRISBANE, Calif., Nov. 4
- Osteotech Secures 10-Year Tissue Supply Agreement-EATONTOWN, N.J., Nov. 4
- Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors-CARLSBAD, Calif., Nov. 4
- Foamix Expands International Patent Protection for its Emollient Foam Platform-REHOVOT, Israel, November 4
- Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell-SEATTLE, Nov. 4
- FDA Grants Orphan Drug Designation for TNFerade(TM)-GAITHERSBURG, Md., Nov. 4
- BD Announces Results for Fourth Fiscal Quarter and Full Year-FRANKLIN LAKES, N.J., Nov. 4
- Cambrex Reports Third Quarter 2009 Results-EAST RUTHERFORD, N.J., Nov. 3
- VIVUS Reports Third Quarter 2009 Highlights and Financial Results-MOUNTAIN VIEW, Calif., Nov. 3
- Foamix Extends Collaboration with Galderma-REHOVOT, Israel, November 3
- YM BIOSCIENCES REPORTS POSITIVE NIMOTUZUMAB FOUR-YEAR SURVIVAL DATA PRESENTED AT ASTRO 2009-MISSISSAUGA, ON, Nov. 2
- New ChartMaxx(R) V5.5 with Recovery Audit Contractor (RAC) Manager Helps Hospitals Handle RAC Audit Requests-CINCINNATI, Nov. 2
- Video: Boston Scientific Announces European Approval and Launch of Platinum Chromium PROMUS(R) Element(TM) Stent System-NATICK, Mass., Nov. 2
- Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday, November 4, 2009, After Close of U.S.-Based Financial Markets-SAN CARLOS, Calif., Oct. 29
- ViroPharma to Present at Three November Healthcare Conferences-EXTON, Pa., Oct. 29
- Techne Corporation Declares Dividend-MINNEAPOLIS, Oct. 29
- NOVAVAX to Present at Oppenheimer 20th Annual Healthcare Conference-ROCKVILLE, Md., Oct. 29
- China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol 'NBS'-NEW YORK, Oct. 29
- Cell Therapeutics, Inc.'s (CTI) Presentation at BIO Investor Forum to be Webcast-SEATTLE, Oct. 29
- Novocell Receives a Disease Team Award for $20 Million from the California Institute for Regenerative Medicine to Develop a Stem Cell Therapy for the Treatment of Diabetes-SAN DIEGO, Oct. 28
- Cell Biosciences Completes Acquisition of Alpha Innotech-SANTA CLARA, Calif., Oct. 28
- Neurocrine Biosciences Reports Third Quarter 2009 Results-SAN DIEGO, Oct. 28
- Correction - LPBP Inc. announces final distribution-TORONTO, Oct. 28
- Trana Discovery and Southern Research Institute Find Bioactive HIV Antiviral Compounds-CARY, N.C. and BIRMINGHAM, Ala., Oct. 28
- Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs-HOERSHOLM, Denmark and SAN DIEGO, California, Octo
- New England's Largest Environmental Lab Acquires Boston Analytical-WESTBOROUGH, Mass., Oct. 28
- Voler Systems Reports 50% Growth-SUNNYVALE, Calif., Oct. 28
- Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India-ROCKVILLE, Md., Oct. 28
- GenVec Announces Third Quarter 2009 Results Conference Call-GAITHERSBURG, Md., Oct. 28
- PDL BioPharma Announces Pricing of $300,000,000 Securitization Transaction-INCLINE VILLAGE, Nev., Oct. 28
- Nektar Completes Enrollment Ahead of Schedule in Phase 2 Clinical Trial Evaluating NKTR-102 in Patients with Platinum-Resistant Ovarian Cancer-SAN CARLOS, Calif., Oct. 28
- PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results-BOSTON, Oct. 27
- 3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 2009-SHENYANG, China, Oct. 27
- Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society-SAN DIEGO, Oct. 27
- ClinOps, LLC Enhances Senior Management Team With Addition of Connie Andrews as Senior Vice President of Clinical Operations-SAN FRANCISCO, Oct. 26
- BioMarin Acquires Huxley Pharmaceuticals, Inc.-NOVATO, Calif., Oct. 26
- Sequenom Announces Paul Maier to Become Interim Chief Financial Officer-SAN DIEGO, Oct. 26
- MolSoft's New Technology Brings Online Publications to Life in Fully Interactive 3D-SAN DIEGO, Oct. 26
- 32 Women Seeking $250 Million to Build Billion Dollar Life Sciences Companies-NEW YORK, Oct. 26
- Cell Therapeutics, Inc. (CTI) to Present at 8th Annual BIO Investor Forum-SEATTLE, Oct. 26
- LPBP Inc. announces final distribution-TORONTO, Oct. 23
- avVaa World Health Care Products Inc. Announces Third Media Test-LUMBY, BC, Oct. 23
- GenVault Corporation to Present at the 2009 BIOCOM Investor Conference-CARLSBAD, Calif., Oct. 23
- New Study on Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII Shows Administration of Vyvanse Through Two Different Routes Demonstrated a Similar Pharmacokinetic Profile-PHILADELPHIA, Oct. 22
- Gen-Probe Completes Acquisition of Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases-SAN DIEGO, Oct. 22
- New Study on Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII Shows Administration of Vyvanse Through Two Different Routes Demonstrated a Similar Pharmacokinetic Profile-PHILADELPHIA, Oct. 22
- Systagenix Unveils SILVERCEL* Non-Adherent Silver Hydro Alginate Dressing-LONDON, October 22
- StemCyte Selected as a Technology Fast 500 Award Winner-COVINA, Calif., Oct. 22
- WuXi PharmaTech Appoints Dr. Hui Cai as Vice President of Business Development-SHANGHAI, Oct. 22
- Update on NVA237 and QVA149 for Chronic Obstructive Pulmonary Disease-TOKYO, October 22
- Regado Biosciences to Present at the 8th Annual BIO Investor Forum on October 29, 2009-BASKING RIDGE, N.J., Oct. 22
- ZyGEM and Phthisis Diagnostics Partner to Produce Novel Products for the Detection of Pathogens in Complex Samples-SOLANA BEACH, Calif., HAMILTON, New Zealand, &
- Pixantrone Produces High Rates of Complete Remission in Multiple Relapsed and Refractory Indolent and Aggressive Non-Hodgkin's Lymphoma-SEATTLE, Oct. 22
- Kendle's TrialEAS(TM) Electronic Adjudication System Named 'Best Technological Development in Clinical Trials - Software Solution' in GCPj Clinical Research Excellence Awards-CINCINNATI, Oct. 21
- Crux Biomedical Awarded Patent for Its Novel Blood Filter-MENLO PARK, Calif., Oct. 21
- Myriant Technologies LLC Announces Appointment of Science Advisory Board Members-QUINCY, Mass., Oct. 21
- China Medical Technologies to Exhibit its Products at China International Medical Equipment Fair in Chengdu, China-BEIJING, Oct. 21
- Ohio Bioscience Industry Leads Midwest, Among Best in Nation as Investment Destination-COLUMBUS, Ohio, Oct. 21
- Ikaria Receives Award for Excellence by New Jersey Business & Industry Association-CLINTON, N.J., Oct. 21
- AutoImmune Inc. Initiates Strategic Alternatives Process-PASADENA, Calif., Oct. 21
- Novavax and Xcellerex Announce Collaboration to Develop Large-scale Manufacturing Process for 2009 H1N1 Influenza VLP Vaccine-ROCKVILLE, Md. and MARLBOROUGH, Mass., Oct. 21
- Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA-CAMBRIDGE, Massachusetts, October 21
- Delcath Systems, Inc. Completes Phase III Study Enrollment-NEW YORK, Oct. 21
- Oncolytics Biotech(R) Inc. Announces Investment in Private Biotechnology Company-CALGARY, Oct. 20
- NuVasive Reports Third Quarter 2009 Financial Results-SAN DIEGO, Oct. 20
- Amylin Pharmaceuticals Reports Third Quarter Financial Results-SAN DIEGO, Calif., Oct. 20
- Colorado Center for Reproductive Medicine Improves Pregnancy and Implantation Rates Using Comprehensive Chromosomal Screening of IVF Embryos-DENVER, Oct. 20
- Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 27, 2009 to Discuss Third Quarter 2009 Results-WALTHAM, Mass., Oct. 20
- New Data Presented at ACR Meeting Demonstrates Colcrys(TM) (Colchicine, USP) Significantly Reduces Pain of Acute Gout Flare Within 24 Hours With Side Effects Comparable to Placebo-PHILADELPHIA, Oct. 19
- Newly Published Clinical Data Shows Caldolor(R) (Ibuprofen) Injection Reduces Opioid Use While Improving Pain Relief in Post-Operative Patients-NASHVILLE, Tenn., Oct. 19
- New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis-PHILADELPHIA, Oct. 19
- AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin (AEZS-130) as First Oral Diagnostic Test for Growth Hormone Deficiency-QUEBEC CITY, Oct. 19
- Summerhill Biomass Systems Unveils Solid Biomass Technology System at Syracuse Expo-SYRACUSE, N.Y., Oct. 16
- Garner to Lead Virginia Bioinformatics Institute-BLACKSBURG, Va., Oct. 16
- EPIX Pharmaceuticals Announces FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimer's Disease Patient-WELLESLEY Hills, Mass., Oct. 16
- American Association for the Study of Liver Diseases (AASLD) President's Press Conference-BOSTON, Oct. 16
- Resverlogix Updates Shareholders on Accelerated Clinical Trial Plan-CALGARY, Oct. 16
- Grifols Breaks Ground on New National Testing Laboratory-SAN MARCOS, Texas, Oct. 16
- MACTEC and MGM Innova Announce Strategic Alliance in Carbon Management Services-ALPHARETTA, Ga. and MIAMI, Oct. 16
- Amgen Announces Webcast of 2009 Third Quarter Financial Results-THOUSAND OAKS, Calif., Oct. 15
- Nutrition 21 Announces Financial Results for Q4 of Fiscal 2009 and Full Year Fiscal 2009-PURCHASE, N.Y., Oct. 15
- ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26-SAN DIEGO, Oct. 15
- Transposagen Expands Field of Use for piggyBac Technology-LEXINGTON, Ky., Oct. 15
- Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option-EAST BRUNSWICK, N.J., Oct. 15
- SIRO Clinpharm Strengthens its Clinical Trials Supplies Service Offering in India-MUMBAI, India, Oct. 15
- China Integrated Energy, Inc. Announces Preliminary Third Quarter Financial Results and Increases Full Year Guidance-XI'AN, China, Oct. 15
- Department of Energy Grants BlueFire Approval for Site Change-IRVINE, Calif., Oct. 15
- ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease-MILWAUKEE, Oct. 14
- Athera Receives Allowance of Two Key Patents-STOCKHOLM, October 14
- Dr. Floyd Bloom Joins aTyr Pharma's Scientific Advisory Board-SAN DIEGO, Oct. 14
- Sosei Announces Deal With UK Biotech Company-TOKYO, Japan, October 14
- The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.-RESEARCH TRIANGLE PARK, N.C. and MIAMI, Oct. 13
- Cepheid Schedules 2009 Third Quarter Financial Results Announcement and Webcast-SUNNYVALE, Calif., Oct. 13
- SpectraScience Engages European Contract Research Organization to Manage Clinical Trials-SAN DIEGO, Oct. 13
- New Effort to Battle Antibiotic Resistance Rallies Researchers Throughout Harvard University-BOSTON, Oct. 13
- Ground-Breaking Innovation: Natural Protection Against Infectious Diseases by Human-Milk-Oligosaccharide Fucosyllactose-BONN and RHEINBREITBACH, Germany, October 13
- Anpath Group, Inc. Continues to Increase Market Share in Korea-MOORESVILLE, N.C., Oct. 13
- Ipsen and Debiopharm Group Announce That Decapeptyl(R)(triptorelin embonate) 6-month Successfully Completes the European Decentralised Procedure for the Treatment of Locally Advanced or Metastatic Prostate Cancer-LAUSANNE, Switzerland and PARIS, October 13
- AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy-AMSTERDAM, October 13
- Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of Directors-SEATTLE, Oct. 12
- ImaginAb, Inc. and BZL Biologics, LLC Conclude Licensing Agreement for Imaging Rights to huJ591/Prostate-Specific Membrane Antigen (PSMA)-INGLEWOOD, Calif., Oct. 12
- China Pharma Holdings, Inc. to Present at the Roth China Conference on October 14 at 12:00 pm ET-HAIKOU CITY, China, Oct. 12
- Prolifiq and EthicsPoint Announce Partnership: 'Automatic Alerts' Help Life Sciences Engage in Good Promotional Practices-WASHINGTON, Oct. 12
- Health Robotics Announces First Five i.v.STATION(TM) Robot Shipments and Receipt of 3L/3T Innovation Award-BOZEN, Italy, October 12
- New Survey Shows Devastating Impact of Rheumatoid Arthritis Pain on Intimate Relations-PHILADELPHIA, October 10
- Fibrocell Science, Inc. Reports Outcome of FDA Advisory Committee Meeting on Azfibrocel-T for Wrinkles-EXTON, Pa., Oct. 9
- Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference-EXTON, Pa., Oct. 9
- OncoGenex Pharmaceuticals CEO Named Canada's Pacific Ernst & Young's Entrepreneur Of The Year(R) in the Health Sciences Category-BOTHELL, WA, and VANCOUVER, Oct. 9
- Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute-OMAHA, Neb., Oct. 8
- Dominion Diagnostics Continues To Lead Through 'On Demand' Laboratory Science-NORTH KINGSTOWN, R.I., Oct. 7
- Oppenheimer's Investment Bank Continues Expansion -- Lance Alstodt Named Managing Director - Healthcare-NEW YORK, Oct. 7
- Gen-Probe to Acquire Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases, for $60 Million in Cash Plus Potential Milestone Payments-SAN DIEGO, Oct. 6
- BD Announces FDA 510(k) Clearance of BD Vacutainer(R) Rapid Serum Blood Collection Tube-FRANKLIN LAKES, N.J., Oct. 6
- SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector-HORSHAM, Pa. and KENILWORTH, N.J., Oct. 6
- Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech-NEW YORK, Oct. 6
- Vantia Therapeutics' VA111913 Enters Phase II Proof-of-Concept Trials for Dysmenorrhoea Phase I Results Show VA111913 to be Safe and Well Tolerated-SOUTHAMPTON, England, October 6
- BioWa Announces Second Japanese License of POTELLIGENT(R) Technology to Otsuka Pharmaceutical-PRINCETON, N.J., Oct. 5
- Verenium Announces Proposed Public Offering of Common Stock-CAMBRIDGE, Mass., Oct. 5
- FDA Orders Postmarket Surveillance Studies on Certain Spinal Systems-SILVER SPRINGS, Md., Oct. 5
- EMD Serono, Inc. Named as a Top Employer by Science Magazine-ROCKLAND, Mass., Oct. 5
- AMERIGROUP Foundation Supports Groundbreaking on Grommet Island Park for People With Disabilities-VIRGINIA BEACH, Va., Oct. 4, 2009
- Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick, Maryland-FREDERICK, Md., Oct. 2
- Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement with the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers-CALGARY, Oct. 2
- Oncolytics Biotech(R) Inc. Announces Phase 3 Update Conference Call-CALGARY, Oct. 1
- PDL BioPharma Completes October 1 Special Dividend Payment-INCLINE VILLAGE, Nev., Oct. 1
- Neurocrine Biosciences Amends Corporate Headquarters Lease-SAN DIEGO, Oct. 1
- Health Strategies Group Introduces Oncology Performance Edge-LAMBERTVILLE, N.J., Oct. 1
- Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award-RICHMOND, Calif., Oct. 1
- OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer-PHILADELPHIA, Oct. 1
- Commercial Insurance Buyers Benefit From Ample Capacity-KANSAS CITY, Mo. and LONDON, Sept. 30
- Biotel Announces Fourth Quarter and Year End Results-MINNEAPOLIS, Sept. 30
- The National Park Foundation and Olympus Announce Winner of the First-Ever 'Your Parks' Video Challenge-WASHINGTON, Sept. 30
- /C O R R E C T I O N -- International Business Forum/-MASSAPEQUA, N.Y., Sept. 29
- IVT Announces the Agenda for Their 15th Annual Validation Week Conference-WOBURN, Mass., Sept. 30
- /C O R R E C T I O N -- Soligenix, Inc./-PRINCETON, N.J., Sept. 30
- InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting-LOS ALTOS, Calif., Sept. 30
- AEterna Zentaris: Thorough QT Trial with Cetrorelix in Benign Prostatic Hyperplasia Meets Primary Endpoint-QUEBEC CITY, Sept. 30
- Ontario Institute for Cancer Research Validates NEBNext(TM) DNA Sample Preparation Reagents from New England Biolabs for use in Next Generation Sequencing-IPSWICH, Mass., Sept. 29
- Resverlogix RVX-208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers-CALGARY, Sept. 29
- Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO-PLEASANTON, Calif., Sept. 29
- AEterna Zentaris Partner, Keryx, Presented Updated Phase 2 Data on Perifosine (KRX-0401) for the Treatment of Advanced Metastatic Renal Cell Carcinoma at 8th International Kidney Cancer Symposium in Chicago-QUEBEC CITY, Sept. 29
- Raptor Pharmaceuticals and TorreyPines Therapeutics Receive Stockholder Approvals to Merge-NOVATO, Calif.,, Sept. 28
- Pacific Biometrics Reports Record Operating Results for FY2009-SEATTLE, September 28, 2009
- Health Robotics Signs Contract With People's Republic of China's Government-Owned Distribution Channel-BOZEN, Italy, September 28
- VIVUS to Present at the JMP Securities Healthcare Focus Conference-MOUNTAIN VIEW, Calif., Sept. 28
- Optimer Pharmaceuticals to Present at October 2009 Investor Conferences-SAN DIEGO, Sept. 28
- Wyeth Receives Positive Opinion from European Regulators for its 13-valent Pneumococcal Candidate Vaccine for Infants and Young Children-COLLEGEVILLE, Pa., Sept. 25
- VaxGen Congratulates HIV Prime-Boost Vaccine Study Collaborators and Clarifies Commercial Rights-SOUTH SAN FRANCISCO, Calif., Sept. 25
- China Sky One Medical, Inc. Reports Outcome of Annual Meeting of Shareholders-HARBIN, China, Sept. 25
- YM BIOSCIENCES REPORTS FISCAL YEAR END 2009 OPERATIONAL AND FINANCIAL RESULTS-MISSISSAUGA, ON, Sept. 25
- SENOMYX ANNOUNCES MANAGEMENT TEAM PROMOTIONS-SAN DIEGO, CA, September 24, 2009
- Vikas Nanda, PhD, Earns New Innovator Award from NIH - Research May Impact Treatment of Cancer, Lupus and other Autoimmune Disorders-NEW BRUNSWICK, N.J., Sept. 24
- Oncolytics Biotech(R) Inc. Announces Reovirus and Cisplatin Research Supports U.S. Phase 2 Metastatic Melanoma Trial-CALGARY, Sept. 24
- Michigan Life Science and Innovation Center Opens in Former Pfizer Facility-PLYMOUTH TOWNSHIP, Mich., Sept. 24
- Bionovo to Present on Novel Female-Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society-EMERYVILLE, Calif., Sept. 24
- Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report-NEW YORK, Sept. 24
- Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems-Hopkinton, Mass., Sept. 24
- Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report-NEW YORK, Sept. 24
- Reportlinker Adds Stem Cell Therapeutics Markets Report-NEW YORK, Sept. 24
- Peptimmune to Collaborate on Dengue Virus Vaccine and Point-Of-Care Diagnostic With Two DOD Biomedical Research Facilities-CAMBRIDGE, Mass., Sept. 24
- Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event-SEATTLE and NEW YORK, Sept. 24
- Imagenetix, Inc. to Present at the 2009 RedChip New York Equities Conference-SAN DIEGO, Sept. 24
- Abbott Hosts Conference Call for Third-Quarter Earnings-ABBOTT PARK, Ill., Sept. 24
- Tianyin Pharmaceutical Co., Inc. Reports Record Fiscal 2009 Financials With $7.9 Million in Net Income-CHENGDU, China, Sept. 24
- New Cardiovascular Biomarker Available for Scientist in North America-SALEM, New Hampshire, and STOCKHOLM, September 24
- ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease-LEUVEN, Belgium, September 24
- Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy-ATLANTA, Sept. 24
- Leaders in Scientific, Economic and Biopharmaceutical Innovation to Gather at 2009 Prix Galien USA Gala Awards Ceremony-NEW YORK, Sept. 24
- Bi-County Partnership Looks to Boost Regional Economic Vitality-RIVERSIDE, Calif., Sept. 24
- US Oncology Announces Election of Two New Members to Its Board of Directors-THE WOODLANDS, Texas, Sept. 24
- Neogen Reports 18% Increase in Net Income, 12% Increase in Revenues-LANSING, Mich., Sept. 24
- MAQUET Cardiovascular Announces Leading Robotic Heart Surgeon Performs First Beating Heart Fully Endoscopic Bypass Surgery Using Miniaturized Cardiopulmonary Bypass System-WAYNE, N.J., Sept. 24
- Axial Biotech Announces Commercial Availability of SCOLISCORE(TM) AIS Prognostic Test-SALT LAKE CITY, Sept. 24
- Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009-SAN DIEGO, Calif., INDIANAPOLIS, Ind., and CAMBRID
- China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS-TAI'AN, China, Sept. 24
- Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial-CALGARY, Sept. 24
- New Cardiovascular Biomarker Available for Scientist in North America-SALEM, New Hampshire, and STOCKHOLM, September 24
- Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer-THOUSAND OAKS, Calif., Sept. 24
- AVAC Praises Thai AIDS Vaccine Trial Collaborators and Volunteers for Historic Study-NEW YORK, Sept. 24
- Thomson Reuters Predicts Nobel Laureates-PHILADELPHIA and LONDON, Sept. 24
- Alexandria Real Estate Equities, Inc. Announces Public Follow-on Offering of 3,000,000 Shares of Common Stock-PASADENA, Calif., Sept. 23
- Compendia Bioscience Announces the Release of Oncomine 4 Research Edition-ANN ARBOR, Mich., Sept. 23
- Spherix Incorporated Announces Annual Shareholders Meeting Date-BETHESDA, Md., Sept. 23
- Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial-SAN FRANCISCO, Sept. 23
- Max Neeman International to Open Phase I/IIa Unit-RESEARCH TRIANGLE PARK, N.C., Sept. 23
- FY 2010 Federal Biodefense Spending-BALTIMORE, Sept. 23
- AMPAC Fine Chemicals Validates Continuous Extraction Process for API Manufacture-RANCHO CORDOVA, Calif., Sept. 23
|
See your news on Entrepreneur.com and other Web sites. How? Distribute a press release through PR Newswire. For a limited time, get a 1-Year Membership to PR Newswire FREE of charge.
FIND OUT MORE »
|